The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics
Open accessAbstract
With tens of thousands of plant species on earth, we are endowed with an enormous wealth of medicinal remedies from Mother Nature. Natural products and their derivatives represent more than 50% of all the drugs in modern therapeutics. Because of the low success rate and huge capital investment need, the research and development of conventional drugs are very costly and difficult. Over the past few decades, researchers have focused on drug discovery from herbal medicines or botanical sources, an important group of complementary and alternative medicine (CAM) therapy. With a long history of herbal usage for the clinical management of a variety of diseases in indigenous cultures, the success rate of developing a new drug from herbal medicinal preparations should, in theory, be higher than that from chemical synthesis. While the endeavor for drug discovery from herbal medicines is “experience driven,” the search for a therapeutically useful synthetic drug, like “looking for a needle in a haystack,” is a daunting task. In this paper, we first illustrated various approaches of drug discovery from herbal medicines. Typical examples of successful drug discovery from botanical sources were given. In addition, problems in drug discovery from herbal medicines were described and possible solutions were proposed. The prospect of drug discovery from herbal medicines in the postgenomic era was made with the provision of future directions in this area of drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
Dai, J., & Mumper, R. J. (2010) · Molecules · doi:10.3390/molecules15107313 · Cited by 4,506
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Medicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161 · cited 1×
“By 2000, only about 500 drug targets had been reported [136, 137], among which only 120 drug targets are actually marketed [138].”
BackgroundInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Antioxidant and prooxidant properties of flavonoids
Procházková, D., Boušová, I., & Wilhelmová, N. (2011) · Fitoterapia · doi:10.1016/j.fitote.2011.01.018 · Cited by 1,559
PubChem: a public information system for analyzing bioactivities of small molecules
Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., & Bryant, S. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp456 · Cited by 1,467
1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Extraction, Isolation And Characterization Of Bioactive Compounds From Plants’ Extracts
Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K., & Latha, L. (2010) · African Journal of Traditional, Complementary and Alternative Medicines · doi:10.4314/ajtcam.v8i1.60483 · Cited by 1,456
Napoli, C., Lemieux, C., & Jorgensen, R. (1990) · The Plant Cell · doi:10.2307/3869076 · Cited by 1,101
HDAC family: What are the cancer relevant targets?
Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.016 · Cited by 1,069
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920
Zhou, H., S. Beevers, C., & Huang, S. (2011) · Current Drug Targets · doi:10.2174/138945011794815356 · Cited by 715
The anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis
Xue, R., Fang, Z., Zhang, M., Yi, Z., Wen, C., & Shi, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1100 · Cited by 617
Flavones and flavone synthases
Martens, S., & Mithöfer, A. (2005) · Phytochemistry · doi:10.1016/j.phytochem.2005.07.013 · Cited by 613
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome
Idro, R., Marsh, K., John, C. C., & Newton, C. R. J. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181eee738 · Cited by 568
Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine
Panossian, A., & Wikman, G. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.04.020 · Cited by 522
Network analyses in systems pharmacology
Berger, S. I., & Iyengar, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp465 · Cited by 510
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis
van der Worp, H. B., Sena, E. S., Donnan, G. A., Howells, D. W., & Macleod, M. R. (2007) · Brain · doi:10.1093/brain/awm083 · Cited by 498
Ayurveda and natural products drug discovery
Patwardhan, B., Vaidya, A. D. B., & Chorghade, M. S. (2004) · Cited by 450
The druggable genome: an update
Russ, A. P., & Lampel, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03666-4 · Cited by 424
Itoh, Y., Ishikawa, M., Naito, M., & Hashimoto, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100691p · Cited by 404
Anticancer Drugs from Marine Flora: An Overview
Sithranga Boopathy, N., & Kathiresan, K. (2010) · Journal of Oncology · doi:10.1155/2010/214186 · Cited by 394
Screening Plants for New Medicines
Wilson, E., & Peter, F. M. (1988) · Cited by 392
Dragon's blood: Botany, chemistry and therapeutic uses
Gupta, D., Bleakley, B. H., & Gupta, R. K. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.018 · Cited by 386
Sinha, A. K., Sharma, U. K., & Sharma, N. (2008) · International Journal of Food Sciences and Nutrition · doi:10.1080/09687630701539350 · Cited by 372
PubChem as a public resource for drug discovery
Li, Q., Cheng, T., Wang, Y., & Bryant, S. H. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.10.003 · Cited by 365
The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao)
Brown, G. D. (2010) · Molecules · doi:10.3390/molecules15117603 · Cited by 363
Immunomodulatory dietary polysaccharides: a systematic review of the literature
Ramberg, J. E., Nelson, E. D., & Sinnott, R. A. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-54 · Cited by 354
Winslow, L. C., & Kroll, D. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.20.2192 · Cited by 351
Systems approaches to polypharmacology and drug discovery.
Boran, A. D. W., & Iyengar, R. (2010) · PubMed · Cited by 339
Jäger, A. K., & Saaby, L. (2011) · Molecules · doi:10.3390/molecules16021471 · Cited by 330
Berberine: a potential phytochemical with multispectrum therapeutic activities
Vuddanda, P. R., Chakraborty, S., & Singh, S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.517745 · Cited by 316
Next‐generation antimalarial drugs: hybrid molecules as a new strategy in drug design
Muregi, F. W., & Ishih, A. (2010) · Drug Development Research · doi:10.1002/ddr.20345 · Cited by 310
Diabetes is an inflammatory disease: evidence from traditional Chinese medicines
Xie, W., & Du, L. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01336.x · Cited by 304
An overview of the PubChem BioAssay resource
Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B. A., Suzek, T. O., Wang, J., Xiao, J., Zhang, J., & Bryant, S. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp965 · Cited by 295
PDTD: a web-accessible protein database for drug target identification
Gao, Z., Li, H., Zhang, H., Liu, X., Kang, L., Luo, X., Zhu, W., Chen, K., Wang, X., & Jiang, H. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-104 · Cited by 288
(2009) · PubMed · Cited by 285
Data completeness—the Achilles heel of drug-target networks
Mestres, J., Gregori-Puigjané, E., Valverde, S., & Solé, R. V. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-983 · Cited by 265
Newman, J. D., Marshall, J., Chang, M., Nowroozi, F., Paradise, E., Pitera, D., Newman, K. L., & Keasling, J. D. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21017 · Cited by 257 · cited 1×
“In addition, Escherichia coli can produce terpene amorpha-4, 11diene, a precursor of artemisinin [236].”
BackgroundIoannidis, J. P. A. (2011) · JAMA · doi:10.1001/jama.2011.713 · Cited by 252
The role of quantum mechanics in structure-based drug design
Raha, K., Peters, M. B., Wang, B., Yu, N., Wollacott, A. M., Westerhoff, L. M., & Merz, K. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.006 · Cited by 252
Analysis of Schisandra chinensis and Schisandra sphenanthera
Lu, Y., & Chen, D.-F. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.09.070 · Cited by 249
Xie, L., Li, J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000387 · Cited by 247
Artemisinin and its derivatives: an important new class of antimalarial agents
Balint, G. A. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00140-1 · Cited by 244
Chen, X., Zhou, H., Liu, Y. B., Wang, J. F., Li, H., Ung, C. Y., Han, L. Y., Cao, Z. W., & Chen, Y. Z. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706945 · Cited by 226
Interactions between traditional Chinese medicines and Western therapeutics.
Chan, E. T., Tan, M., Xin, J., Sudarsanam, S., & Johnson, D. E. (2010) · PubMed · Cited by 218
Decker, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795328355 · Cited by 212
Mahdi, J. G., Mahdi, A. J., Mahdi, A. J., & Bowen, I. D. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00377.x · Cited by 209
Johnston, S. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp020891 · Cited by 207
Zhang, L., Jing, F., Li, F., Li, M., Wang, Y., Wang, G., Sun, X., & Tang, K. (2009) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20080068 · Cited by 206
Nature: a vital source of leads for anticancer drug development
Cragg, G. M., & Newman, D. J. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-009-9123-y · Cited by 202
The history of qing hao in the Chinese materia medica
Hsu, E. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.09.020 · Cited by 199
Eisenbrand, G., Hippe, F., Jakobs, S., & Muehlbeyer, S. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0579-2 · Cited by 197
Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry
Yan, D., Jin, C., Xiao, X.-H., & Dong, X.-P. (2008) · Journal of Biochemical and Biophysical Methods · doi:10.1016/j.jbbm.2007.07.009 · Cited by 186
Azaizeh, H., Saad, B., Khalil, K., & Said, O. (2006) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nel034 · Cited by 181
Identification of drugs that interact with herbs in drug development
Zhou, S.-F., Zhou, Z.-W., Li, C.-G., Chen, X., Yu, X., Xue, C. C., & Herington, A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.004 · Cited by 178
Self-citationYield enhancement strategies for artemisinin production by suspension cultures of Artemisia annua
Baldi, A., & Dixit, V. K. (2008) · Bioresource Technology · doi:10.1016/j.biortech.2007.06.061 · Cited by 176
Chan, E. C. Y., Yap, S., Lau, A. J., Leow, P., Toh, D., & Koh, H. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2864 · Cited by 170
The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled Receptors
Valant, C., Robert Lane, J., Sexton, P. M., & Christopoulos, A. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134514 · Cited by 168
A compilation of bioactive compounds from Ayurveda
Samy, R. P., Pushparaj, P. N., & Gopalakrishnakone, P. (2008) · Bioinformation · doi:10.6026/97320630003100 · Cited by 165
Herb-Drug Interactions and Mechanistic and Clinical Considerations
Chen, X.-W., B. Sneed, K., Pan, S.-Y., Cao, C., R. Kanwar, J., Chew, H., & Zhou, S. F. (2012) · Current Drug Metabolism · doi:10.2174/1389200211209050640 · Cited by 164
Self-citationArtemisinin: current state and perspectives for biotechnological production of an antimalarial drug
Liu, C., Zhao, Y., & Wang, Y. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0452-0 · Cited by 158
Wu, P., Zhang, Z., Wang, F., & Chen, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.186 · Cited by 155
Ginseng leaf-stem: bioactive constituents and pharmacological functions
Wang, H., Peng, D., & Xie, J. (2009) · Chinese Medicine · doi:10.1186/1749-8546-4-20 · Cited by 148
Leonarduzzi, G., Testa, G., Sottero, B., Gamba, P., & Poli, G. (2009) · Current Medicinal Chemistry · doi:10.2174/092986710789957760 · Cited by 144
Rofecoxib (Vioxx) voluntarily withdrawn from market
Sibbald, B. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041606 · Cited by 141
Cooling therapy for acute stroke
den Hertog, H. M., van der Worp, H. B., Tseng, M., & Dippel, D. W. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001247.pub2 · Cited by 140
Improved microwave steam distillation apparatus for isolation of essential oils
Sahraoui, N., Vian, M. A., Bornard, I., Boutekedjiret, C., & Chemat, F. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.09.078 · Cited by 130
Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies
Chen, X., Serag, E. S., Sneed, K., Liang, J., Chew, H., Pan, S., & Zhou, S. F. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797535317 · Cited by 123
Self-citationHuperzine A for Alzheimer's disease
Li, J., Wu, H. M., Zhou, R., Liu, G. J., & Dong, B. R. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005592.pub2 · Cited by 122
Recent pharmacological studies on natural products in China
Zhu, X., Li, X., & Liu, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.027 · Cited by 121
Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia
Zhang, H., Zheng, C. Y., Yan, H., Wang, Z. F., Tang, L. L., Gao, X., & Tang, X. C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.049 · Cited by 119
Krief, S., Martin, M., Grellier, P., Kasenene, J. M., & Sévenet, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3196-3199.2004 · Cited by 114
Biomarkers for chronic pain and analgesia. Part 1: the need, reality, challenges, and solutions.
Borsook, D., Becerra, L. R., & Hargreaves, R. (2011) · PubMed · Cited by 106
Hopkins, P. N., & Hunt, S. C. (2003) · Genetics in Medicine · doi:10.1097/01.gim.0000096375.88710.a6 · Cited by 102
Six New Dammarane-type Triterpene Saponins from the Leaves of Panax ginseng
Dou, D., Chen, Y., Liang, L., Pang, F., Shimizu, N., & Takeda, T. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.442 · Cited by 98
Polysaccharides Isolated from Açaí Fruit Induce Innate Immune Responses
Holderness, J., Schepetkin, I. A., Freedman, B. A., Kirpotina, L. N., Quinn, M. T., Hedges, J. F., & Jutila, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017301 · Cited by 97
Off-Target Effects of Psychoactive Drugs Revealed by Genome-Wide Assays in Yeast
Ericson, E., Gebbia, M., Heisler, L. E., Wildenhain, J., Tyers, M., Giaever, G., & Nislow, C. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000151 · Cited by 89 · cited 1×
“It enables drug discovery from both natural remedies and synthetics andmakes predictions about the possible therapeutic effects and adverse events, including possible off-target effects, through combination of the structural analyses with analysis of regulatory networks [128, 129].”
BackgroundMetabolic engineering of artemisinin biosynthesis in Artemisia annua L.
Liu, B., Wang, H., Du, Z., Li, G., & Ye, H. (2010) · Plant Cell Reports · doi:10.1007/s00299-010-0967-9 · Cited by 88
Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010024 · Cited by 88
Lenihan, J. R., Tsuruta, H., Diola, D., Renninger, N. S., & Regentin, R. (2008) · Biotechnology Progress · doi:10.1002/btpr.27 · Cited by 87
Walsh, V., & Goodman, J. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00161-6 · Cited by 78
Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase
Zhang, H., Yan, H., & Tang, X. C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9163-z · Cited by 78
Synthetic medicinal chemistry of selected antimalarial natural products
Kumar, V., Mahajan, A., & Chibale, K. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.072 · Cited by 77
GAP Production of TCM Herbs in China
Zhang, B., Peng, Y., Zhang, Z., Liu, H., Qi, Y., Liu, S., & Xiao, P. (2010) · Planta Medica · doi:10.1055/s-0030-1250527 · Cited by 77
New Therapeutic Targets for Mood Disorders
Machado‐Vieira, R., Salvadore, G., Diazgranados, N., Ibrahim, L. A., Latov, D. R., Wheeler‐Castillo, C., Baumann, J., Henter, I. D., & Zarate, C. A. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.65 · Cited by 75
ADME Properties of Herbal Medicines in Humans: Evidence, Challenges and Strategies
He, S., Chan, E., & Zhou, S. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795164194 · Cited by 72
Self-citationDiscovery of Artemisinin (Qinghaosu)
Liao, F. (2009) · Molecules · doi:10.3390/molecules14125362 · Cited by 71
An update on huperzine A as a treatment for Alzheimer's disease
Little, J. T., Walsh, S. P., & Aisen, P. S. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.209 · Cited by 68
Traditional Chinese medicine information database
WANG, J., ZHOU, H., Han, L., Chen, X., Chen, Y., & Cao, Z. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.03.010 · Cited by 66
New Perspectives on Chinese Herbal Medicine (Zhong‐Yao) Research and Development
Pan, S.-Y., Chen, S., Dong, H.-G., Yu, Z., Dong, J.-C., Long, Z.-X., Fong, W. F., Han, Y., & Ko, K. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neq056 · Cited by 65
Self-citationBridging quantum mechanics and structure-based drug design
Vivo, M. D. (2010) · Frontiers in bioscience · doi:10.2741/3809 · Cited by 65
Role of Huperzine a in the Treatment of Alzheimer's Disease
Desilets, A. R., Gickas, J. J., & Dunican, K. C. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l402 · Cited by 64
Origins of Plant Derived Medicines
Maridass, M., & Britto, A. J. D. (2008) · OpenSIUC (Southern Illinois University Carbondale) · Cited by 61
Yichong, L., & Yl, W. (1998) · PubMed · Cited by 59
Genetics of hypertension. Current status.
Butler, M. G. (2010) · PubMed · Cited by 58
Pan, S.-Y., Yang, R., Dong, H., Yu, Z., & Ko, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.011 · Cited by 57
Self-citationBoran, A. D. W., & Iyengar, R. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20191 · Cited by 56
Khachik, F., Steck, A., & Pfander, H. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980823w · Cited by 54
Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice
Pan, S.-Y., Dong, H., Zhao, X.-Y., Xiang, C.-J., Fang, H., Fong, W. F., Yu, Z., & Ko, K. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.3.0017 · Cited by 53
Self-citationArtemisinin, Promising Lead Natural Product for Various Drug Developments
Lee, S. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707780363837 · Cited by 53
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines
Earl, P. L., Cotter, C. A., Moss, B., VanCott, T. C., Currier, J. R., Eller, L. A., McCutchan, F. E., Birx, D. L., Michael, N. L., Marovich, M., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.039 · Cited by 52
Lima, J. P. D. S. N., dos Santos, L. V., Sasse, E. C., Lima, C. S. P., & Sasse, A. D. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f2451c · Cited by 50
O’Neill, P. M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.9.1117 · Cited by 48
Fang, L., Jumpertz, S., Zhang, Y., Appenroth, D., Fleck, C., Mohr, K., Tränkle, C., & Decker, M. W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901616h · Cited by 45
Gordaliza, M. (2009) · Marine Drugs · doi:10.3390/md7040833 · Cited by 45
Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications
Galeazzi, R. (2009) · Current Computer - Aided Drug Design · doi:10.2174/157340909789577847 · Cited by 42
van der Hoorn, J., Jukema, J. W., Havekes, L. M., Lundholm, E., Camejo, G., Rensen, P. C. N., & Princen, H. M. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00109.x · Cited by 39
Antimalarial Peroxide Dyads from Natural Artemisinin and Hydroxyalkylated 1,2,4-Trioxanes
Griesbeck, A. G., Neudörfl, J., Hörauf, A., Specht, S., & Raabe, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002523 · Cited by 37
Chemistry of artemisinin: an overview
Webster, H. K., & Lehnert, E. K. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90467-7 · Cited by 36
Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells
Chu, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i19.2379 · Cited by 33
Triterpenoid Saponins from Leaves and Stems ofPanax QuinquefoliumL
Wang, J., Lia, W., Yi, S., Tezuka, Y., Kadota, S., & Li, X. (2001) · Journal of Asian Natural Products Research · doi:10.1080/10286020108041379 · Cited by 32
Pan, S.-Y., Yu, Q., Zhang, Y., Wang, X.-Y., Sun, N., Yu, Z., & Ko, K. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-120 · Cited by 32
Self-citationThe Role of Proteomics in Osteoarthritis Pathogenesis Research
Ruíz‐Romero, C., & Blanco, F. J. (2009) · Current Drug Targets · doi:10.2174/138945009788488404 · Cited by 27
New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder
Figee, M., & Denys, D. A. J. P. (2009) · CNS Spectrums · doi:10.1017/s1092852900027255 · Cited by 26
Antipsychotic Drug Development
Kim, D. H., & Stahl, S. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_47 · Cited by 25
Epigenetic mechanisms in Alzheimer's disease: progress but much to do
Balázs, R., Vernon, J. D. R., & Hardy, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.024 · Cited by 24
Im, A., Kim, Y., Uddin, M. R., Lee, H. W., Chae, S. W., Kim, Y. H., Jung, W. S., Kang, B. J., Mun, C. S., & Lee, M. Y. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/517965 · Cited by 24
A novel experimental model of acute hypertriglyceridemia induced by schisandrin B
Pan, S.-Y., Dong, H., Han, Y., Li, W.-Y., Zhao, X.-Y., & Ko, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.001 · Cited by 23
Self-citationD’Onofrio, P. M., Thayapararajah, M., Lysko, M. D., Magharious, M. M., Spratt, S. K., Lee, G., Ando, D. G., Surosky, R. T., Fehlings, M. G., & Koeberle, P. D. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1896 · Cited by 19
Barden, C., & Weaver, D. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.001 · Cited by 19
Pan, S.-Y., Yu, Z., Dong, H., Xiang, C.-J., Fong, W. F., & Ko, K. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep070 · Cited by 18
Self-citationTomatoes, lycopene-containing foods and cancer risk
Lippi, G., & Targher, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.59 · Cited by 17
Pan, S.-Y., Dong, H., Yu, Z., Zhao, X.-Y., Xiang, C.-J., Wang, H., Fong, W. F., & Ko, K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.12.0007 · Cited by 17
Self-citationHe, Z., & Xia, W. (2011) · Natural Product Research · doi:10.1080/14786410701592778 · Cited by 17
Pan, S.-Y., Yang, R., Han, Y., Dong, H., Xu-dong, F. E. N. G., Li, N., Geng, W., & Ko, K. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00332.x · Cited by 16
Self-citationvan der Hoorn, J. W., Jukema, J. W., Havekes, L. M., Rensen, P. C. N., Lundholm, E., Camejo, G., & Princen, H. M. G. (2008) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(08)70837-7 · Cited by 15
Efficient four‐drug cocktail therapy targeting amyloid‐β peptide for Alzheimer's disease
Asai, M., Iwata, N., Tomita, T., Iwatsubo, T., Ishiura, S., Saido, T. C., & Maruyama, K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22503 · Cited by 15
The year's new drugs & biologics - 2008
Graul, A. I., Revel, L., Barrionuevo, M., Cruces, E., Rosa, E., Verges, C., Lupone, B., Diaz, N., & Castaner, R. M. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.1.1303754 · Cited by 12
Malaria: severe, life-threatening.
Sheehy, S. H., & Angus, B. (2011) · Europe PMC (PubMed Central) · Cited by 11
Hepatitis C Virus Infection and Immunomodulatory Therapies
Forde, K. A., & Reddy, K. R. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.05.007 · Cited by 10
Tian-tong, B., Gui-fang, T., Liu, G.-T., Run-hua, S., & Zhen-yu, S. (1979) · PubMed · Cited by 10
Sheng, J., Chen, H., & Shen, L. (2009) · PubMed · Cited by 9
Cited by
Plant-Derived Natural Products: A Source for Drug Discovery and Development
Chaachouay, N., & Zidane, L. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010011 · Cited by 1,081
Medicinal plants: Past history and future perspective
Jamshidi-Kia, F., Lorigooini, Z., & Amini-Khoei, H. (2018) · Journal of Herbmed Pharmacology · doi:10.15171/jhp.2018.01 · Cited by 925
Pan, S.-Y., Litscher, G., Gao, S.-H., Zhou, S.-F., Yu, Z.-L., Chen, H.-Q., Zhang, S.-F., Tang, M.-K., Sun, J.-N., & Ko, K.-M. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/525340 · Cited by 593
Self-citationSen, S., & Chakraborty, R. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.05.006 · Cited by 490
Saini, R. K., Sivanesan, I., & Keum, Y.-S. (2016) · 3 Biotech · doi:10.1007/s13205-016-0526-3 · Cited by 485
Metadata
- Authors
- Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N., Ma, D.-L., Han, Y.-F., Fong, W.-F., & Ko, K.-M.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-25
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W2065380210
- Cited by
- 687
- References
- 147
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.